ResearcherNew York UniversityActive in the last 2 years
Koelina Ganguly
Matched on OpenAlex author ID A5112901631. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 47
2019: 2 papers · 2020: none · 2021: 2 papers · 2022: 3 papers · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 2 papers
Papers 12
- NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXCL5/CXCR2 signaling axis. Co-author DOI 10.1016/j.canlet.2026.218269↗
- Hepatocytes promote liver metastasis of pancreatic cancer by providing serine. Co-author DOI 10.1038/s41586-026-11051-z↗
- Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.drup.2024.101146↗
- Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41698-024-00562-5↗
- Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis. Co-author DOI 10.1038/s41388-022-02587-1↗
- Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2022.03.022↗
- Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance. Co-author DOI 10.1053/j.gastro.2021.09.017↗
- Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity. Co-author DOI 10.1053/j.gastro.2022.02.032↗
- SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1128/mcb.00135-21↗
- Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. Co-author DOI 10.1158/0008-5472.can-20-1293↗
- Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. First author DOI 10.1016/j.ebiom.2019.03.056↗
- Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. First author DOI 10.1038/s41598-018-36328-w↗
Closest collaborators
The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Surinder K. Batra · 11 shared papers, 2019–2026 · strength 1.69
- Paper NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXC… DOI 10.1016/j.canlet.2026.218269↗
- Paper Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2024.101146↗
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Jesse L. Cox · 6 shared papers, 2021–2026 · strength 1.00
- Paper NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXC… DOI 10.1016/j.canlet.2026.218269↗
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer… DOI 10.1053/j.gastro.2022.02.032↗
- Sanchita Rauth · 6 shared papers, 2021–2024 · strength 0.91
- Paper Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2024.101146↗
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. DOI 10.1016/j.semcancer.2022.03.022↗
- Sushil Kumar K · 6 shared papers, 2021–2024 · strength 0.91
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. DOI 10.1016/j.semcancer.2022.03.022↗
- Paper Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer… DOI 10.1053/j.gastro.2022.02.032↗
- Ashu Shah · 5 shared papers, 2021–2024 · strength 0.78
- Paper Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2024.101146↗
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. DOI 10.1016/j.semcancer.2022.03.022↗
- Moorthy Palanimuthu Ponnusamy · 5 shared papers, 2021–2024 · strength 0.78
- Paper Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2024.101146↗
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. DOI 10.1016/j.semcancer.2022.03.022↗
- Maneesh Jain · 4 shared papers, 2022–2024 · strength 0.70
- Paper Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. DOI 10.1016/j.drup.2024.101146↗
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer… DOI 10.1053/j.gastro.2022.02.032↗
- Pranita Atri · 5 shared papers, 2019–2024 · strength 0.68
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Chemokine-mucinome interplay in shaping the heterogeneous tumor microenvironment of pancreatic cancer. DOI 10.1016/j.semcancer.2022.03.022↗
- Paper Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Ch… DOI 10.1053/j.gastro.2021.09.017↗
- Satyanarayana Rachagani · 4 shared papers, 2019–2024 · strength 0.52
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis. DOI 10.1038/s41388-022-02587-1↗
- Paper Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. DOI 10.1158/0008-5472.can-20-1293↗
- Paul M. Grandgenett · 3 shared papers, 2019–2026 · strength 0.48
- Paper Hepatocytes promote liver metastasis of pancreatic cancer by providing serine. DOI 10.1038/s41586-026-11051-z↗
- Paper Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer… DOI 10.1053/j.gastro.2022.02.032↗
- Paper Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. DOI 10.1016/j.ebiom.2019.03.056↗
- Apar Kishor Ganti · 2 shared papers, 2024–2026 · strength 0.48
- Sukhwinder Kaur · 4 shared papers, 2019–2022 · strength 0.43
- Paper Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Ch… DOI 10.1053/j.gastro.2021.09.017↗
- Paper Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. DOI 10.1038/s41598-018-36328-w↗
- Paper Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. DOI 10.1158/0008-5472.can-20-1293↗
- Michael Anthony Hollingsworth · 2 shared papers, 2022–2026 · strength 0.40
- Rakesh Bhatia · 3 shared papers, 2021–2023 · strength 0.39
- Paper Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis. DOI 10.1038/s41388-022-02587-1↗
- Paper Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Ch… DOI 10.1053/j.gastro.2021.09.017↗
- Paper SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarci… DOI 10.1128/mcb.00135-21↗
- Ramesh Pothuraju · 2 shared papers, 2021–2026 · strength 0.38
- Paper NR4A2 induces perineural invasion in head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma via CXC… DOI 10.1016/j.canlet.2026.218269↗
- Paper Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. DOI 10.1158/0008-5472.can-20-1293↗
- Joseph Carmicheal · 3 shared papers, 2019–2024 · strength 0.37
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis. DOI 10.1038/s41598-018-36328-w↗
- Paper Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. DOI 10.1016/j.ebiom.2019.03.056↗
- Lynette M. Smith · 3 shared papers, 2019–2024 · strength 0.37
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness. DOI 10.1158/0008-5472.can-20-1293↗
- Paper Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer. DOI 10.1016/j.ebiom.2019.03.056↗
- Muzafar Ahmad Macha · 2 shared papers, 2019–2026 · strength 0.35
- Sushil Kumar · 2 shared papers, 2021–2024 · strength 0.32
- Parthasarathy Seshacharyulu · 2 shared papers, 2021–2024 · strength 0.29
- Paper Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal … DOI 10.1038/s41698-024-00562-5↗
- Paper SUMO Modification of PAF1/PD2 Enables PML Interaction and Promotes Radiation Resistance in Pancreatic Ductal Adenocarci… DOI 10.1128/mcb.00135-21↗
- Christopher M. Thompson · 2 shared papers, 2022–2023 · strength 0.28
- Sanjib Chaudhary · 1 shared paper, 2026 · strength 0.27
- Imayavaramban Lakshmanan · 1 shared paper, 2026 · strength 0.27
- Subodh M. Lele · 1 shared paper, 2026 · strength 0.27
- Douglas E. Biancur · 1 shared paper, 2026 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.